ReidRubsamenMD

PubMed

• Bioinformatic, Biochemical, and Immunological Mining of MHC Class I Restricted T Cell Epitopes for a Marburg Nucleoprotein Microparticle Vaccine.
  Paul E Harris, Scott Burkholz, Charles V Herst, Reid M Rubsamen> ;Vaccines. 2024 Mar 18
• Integrative HLA typing of tumor and adjacent normal tissue can reveal insights into the tumor immune response.
  Sverchkova, A., Burkholz, S., Stratford, R., Clancy, T., Rubsamen, R.> ;BMC Medical Genomics. 2024 Jan 27
• Editorial: Synthetic peptide vaccine platforms targeting tumor-specific antigens: advances and challenges.
  Reid M Rubsamen, Andrew E Sloan> ;Frontiers in Pharmacology. 2024 Jan 1
• 1 citations
  Survivin Expression in Luminal Breast Cancer and Adjacent Normal Tissue for Immuno-Oncology Applications.
  Sharon Wright, Scott R Burkholtz, Cathy Zelinsky, Connor Wittman, Richard T Carback, Paul E Harris, Tikoes Blankenberg, Charles V Herst, Reid M Rubsamen> ;International Journal of Molecular Sciences. 2023 Jul 23
• 4 citations
  Survivin (BIRC5) Peptide Vaccine in the 4T1 Murine Mammary Tumor Model: A Potential Neoadjuvant T Cell Immunotherapy for Triple Negative Breast Cancer: A Preliminary S...
  Scott R Burkholz, Charles V Herst, Richard T Carback, Paul E Harris, Reid M Rubsamen> ;Vaccines. 2023 Mar 13
• 15 citations
  Paired SARS-CoV-2 spike protein mutations observed during ongoing SARS-CoV-2 viral transfer from humans to minks and back to humans.
  Scott Burkholz, Suman Pokhrel, Benjamin R. Kraemer, Daria Mochly-Rosen, Richard Carback, Tom Hodge, Paul L. Harris, Serban Ciotlos, Lu Wang, C. V. Herst, Reid M. Rubsamen> ;Infection, Genetics and Evolution. 2021 Sep 1
• 26 citations
  A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques
  Paul L. Harris, Trevor Brasel, Christopher Massey, C. V. Herst, Scott Burkholz, Peter M. Lloyd, Tikoes Blankenberg, Thomas Bey, Richard Carback, Thomas Hodge, Serban C...> ;Vaccines. 2021 May 18
• 5 citations
  Anti-IL-6 Versus Anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice: Potential Implications for Treating Cytokine Release Syndrome
  Reid M. Rubsamen, Scott Burkholz, Christopher Massey, Trevor Brasel, Tom Hodge, Lu Wang, Charles Herst, Richard Carback, Paul L. Harris> ;Frontiers in Pharmacology. 2020 Sep 23
• 19 citations
  An Approach for a Synthetic CTL Vaccine Design against Zika Flavivirus Using Class I and Class II Epitopes Identified by Computer Modeling.
  Edecio Cunha-Neto, Daniela Santoro Rosa, Paul L. Harris, Tim Olson, Alex Morrow, Serban Ciotlos, Charles Herst, Reid M. Rubsamen> ;Frontiers in Immunology. 2017 Jun 9
• 21 citations
  Eliciting cytotoxic T-lymphocyte responses from synthetic vectors containing one or two epitopes in a C57BL/6 mouse model using peptide-containing biodegradable micros...
  Reid M. Rubsamen, C. V. Herst, Peter M. Lloyd, David Heckerman> ;Vaccine. 2014 Jul 16
• Effects of α-adrenergic blockade on regional myocardial function in canine ischemic myocardium during β-adrenergic blockade
  Masashi Kono, Shigeho Morita, Reid M. Rubsamen> ;Journal of Cardiothoracic and Vascular Anesthesia. 1995 Oct 1
• Join now to see all